Skip to main content

CORRECTION article

Front. Aging Neurosci., 12 October 2018
Sec. Alzheimer's Disease and Related Dementias
Volume 10 - 2018 | https://doi.org/10.3389/fnagi.2018.00322

Corrigendum: Evaluation of Metformin on Cognitive Improvement in Patients With Non-dementia Vascular Cognitive Impairment and Abnormal Glucose Metabolism

This article is a correction to:

  1. Evaluation of Metformin on Cognitive Improvement in Patients With Non-dementia Vascular Cognitive Impairment and Abnormal Glucose Metabolism

    1. Read original article
\r\nYufeng Lin,&#x;Yufeng Lin1,2†Kaiyuan Wang&#x;Kaiyuan Wang3†Chunchao MaChunchao Ma2Xuesong WangXuesong Wang2Zhongying GongZhongying Gong2Rui ZhangRui Zhang2Dawei Zang*Dawei Zang2*Yan Cheng*Yan Cheng1*
  • 1Department of Neurology, Tianjin Medical University General Hospital, Tianjin, China
  • 2Department of Neurology, Tianjin First Center Clinical College of Tianjin Medical University, Tianjin, China
  • 3Department of Anesthesiology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

A Corrigendum on
Evaluation of Metformin on Cognitive Improvement in Patients With Non-dementia Vascular Cognitive Impairment and Abnormal Glucose Metabolism

by Lin, Y., Wang, K., Ma, C., Wang, X., Gong, Z., Zhang, R., et al. (2018). Front. Aging Neurosci. 10:227. doi: 10.3389/fnagi.2018.00227

In the original article, we missed an affiliation for Yufeng Lin. The new affiliations have been added and reordered accordingly.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

The original article has been updated.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: non-dementia vascular cognitive impairment, glucose metabolism disorders, insulin resistance, metformin, carotid intima–media thickness

Citation: Lin Y, Wang K, Ma C, Wang X, Gong Z, Zhang R, Zang D and Cheng Y (2018) Corrigendum: Evaluation of Metformin on Cognitive Improvement in Patients With Non-dementia Vascular Cognitive Impairment and Abnormal Glucose Metabolism. Front. Aging Neurosci. 10:322. doi: 10.3389/fnagi.2018.00322

Received: 21 September 2018; Accepted: 24 September 2018;
Published: 12 October 2018.

Approved by:

Frontiers In Aging Neuroscience Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2018 Lin, Wang, Ma, Wang, Gong, Zhang, Zang and Cheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Dawei Zang, zangdaweiyzx@sina.com
Yan Cheng, cylfl@sohu.com

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.